A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
M.D. Anderson Cancer Center
AstraZeneca
Mayo Clinic
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Transgene
Strand Therapeutics Inc.
Hadassah Medical Organization
Incyte Corporation
Cancer Research UK
MacroGenics
NuCana plc
Medicenna Therapeutics, Inc.
Kymab Limited
BioAtla, Inc.
Simcha IL-18, Inc.
Salubris Biotherapeutics Inc
Pfizer
Innolake Biopharm
Nektar Therapeutics
Nektar Therapeutics
Rubius Therapeutics
Incyte Corporation
Novartis
Incyte Corporation
Novartis
Incyte Corporation
National Cancer Institute (NCI)